Corcept Therapeutics CORT PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's PP&E (net)?
- Corcept Therapeutics (CORT) reported PP&E (net) of $3.17M in Q1 2026.
- How has Corcept Therapeutics's PP&E (net) changed year-over-year?
- Corcept Therapeutics's PP&E (net) increased by 24.7% year-over-year, from $2.54M to $3.17M.
- What is the long-term trend for Corcept Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Corcept Therapeutics's PP&E (net) has grown at a 2.4% compound annual growth rate (CAGR), from $1.68M to $1.89M.
- What does PP&E (net) mean?
- The value of the company's physical assets like buildings and equipment, minus the wear and tear accumulated over time.
- How do you interpret PP&E (net)?
- Growth in this metric indicates ongoing capital investment in infrastructure, while a decline may suggest aging assets or divestment.
- How does PP&E (net) compare across companies?
- Varies significantly based on whether a company owns its manufacturing facilities or outsources production.